Increasing Soluble P-Selectin Levels Predict Higher Peripheral Atherosclerotic Plaque Progression.
Philip SommerMichael SchreinlechnerMaria NoflatscherDaniela LenerFabian MairMarkus TheurlRudolf KirchmairPeter MarschangPublished in: Journal of clinical medicine (2023)
Increasing sP-selectin levels can predict higher atherosclerotic plaque progression as measured by 3D ultrasound. We suggest serial measurements of sP-selectin as an easily measurable biomarker for peripheral atherosclerotic plaque progression.